Development and validation of a renal involvement model for patients with hyperuricemia: A cross‐sectional study
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15374 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Fangfang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Hyperuricemia, Uric Acid, Nomograms, Predictive Value of Tests. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Shanghai Pujiang Young Rheumatologists Training Program, Shanghai Hospital Development Center, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To construct a prediction model for renal involvement in patients with hyperuricemia (HUA) based on logistic regression analysis, to achieve early risk stratification.
Method
In this cross‐sectional study, we collected data from the National Health and Nutrition Examination Survey (NHANES), and constructed a predicted model for renal involvement in HUA patients. The discriminative ability of the model was assessed using the receiver operating characteristic (ROC) curve. Model accuracy was evaluated using the Hosmer‐Lemeshow test and calibration curve, while clinical utility was assessed using decision curve analysis (DCA). Furthermore, internal and external validation cohorts were also applied to validate the model.
Results
A total of 1669 patients from NHANES between 2007 and 2010 were included in the final analysis for modeling and validation. Six predictive factors including age, Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Cr, Uric Acid (UA), and sex were identified by binary logistic regression analysis for renal involvement in HUA patients and used to construct a nomogram with good consistency and accuracy. The AUC values for the predictive model, internal validation, and external validation were 0.881 (95% CI: 0.836–0.926), 0.908 (95% CI: 0.871–0.944), and 0.927 (95% CI: 0.897–0.957), respectively. The calibration curves demonstrated consistency between the nomogram and observed values. The DCA curves of the model and validation cohort indicated good clinical utility.
Conclusion
This study developed a predictive model for renal involvement in hyperuricemia patients with strong predictive performance and validated by internal and external cohorts, aiding in the early detection of high‐risk populations for renal involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
- Institute of Rheumatology, Immunology and Allergy, Fudan University, Shanghai, China.
ORCID-Profile: Xingchen Du, Li Zhao
Förderung
- Shanghai Pujiang Young Rheumatologists Training Program
- Shanghai Hospital Development Center
- National Natural Science Foundation of China
- Shanghai Municipal Hospital Development Center
Zitieren
APA
Chen, F., Du, X., Zhao, L., Wan, W., Zou, H., & Yu, X. (2024). Development and validation of a renal involvement model for patients with hyperuricemia: A cross‐sectional study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15374
Vancouver
Chen F, Du X, Zhao L, Wan W, Zou H, Yu X. Development and validation of a renal involvement model for patients with hyperuricemia: A cross‐sectional study. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15374
BibTeX
@article{Chen2024,
author = {Chen, Fangfang and Du, Xingchen and Zhao, Li and Wan, Weiguo and Zou, Hejian and Yu, Xue},
title = {Development and validation of a renal involvement model for patients with hyperuricemia: A cross‐sectional study},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15374}
}
EUVIMED